Prognosis: Misconception

A few decades ago, nobody really questioned vaccines. They were viewed as a standard part of staying healthy and safe. Today, the number of people questioning vaccines risks prolonging a pandemic that has already killed hundreds of thousands of Americans. How we got to this moment didn’t start with the rollout of vaccines or in March 2020, or even with the election of Donald Trump. Our confidence in vaccines, often isn't even about vaccines. It’s about trust. And that trust has been eroding for a long time. Doubt, a new series from Bloomberg’s Prognosis podcast, looks at the forces that have been breaking down that trust. We'll trace the rise of vaccine skepticism in America to show how we got here — and where we’re going. Doubt launches on March 23. Subscribe to Prognosis today on Apple Podcasts, Spotify or wherever you get your podcasts.

See omnystudio.com/listener for privacy information.

It’s been one year since Coronavirus was declared a global pandemic. And in that time, our lives have changed dramatically. 

The virus has imposed disease, death and loss on the U.S. and the world. It forced sweeping changes to daily life almost overnight. 

For this special episode of Prognosis, Bloomberg reporters Emma Court and Nic Querolo spoke with people across the U.S. about what this last year has been like for them, and how things could change moving forward. 

See omnystudio.com/listener for privacy information.

Israel has had one of the world’s most successful vaccination efforts yet. Now a new study from the country shows the Pfizer vaccine was overwhelmingly effective against the virus. Public-health experts say the Israeli study shows that immunizations could end the pandemic. Naomi Kresge reports on what makes the Israeli study so significant, and why it might point to an eventual way out of the pandemic.

See omnystudio.com/listener for privacy information.

More than 150 years after the end of slavery in the U.S., the net worth of a typical white family is nearly six times greater than that of the average Black family. Season 3 of The Pay Check digs into into how we got to where we are today and what can be done to narrow the yawning racial wealth gap in the U.S.

Jackie Simmons and Rebecca Greenfield co-host the season, which kicks off with a personal story about land Jackie's family acquired some time after slavery that they're on the verge of losing. From there the series explores all the ways the wealth gaps manifests and the radical solutions, like affirmative action, quotas, and reparations, that can potentially lead to greater equality.

See omnystudio.com/listener for privacy information.

Vaccine distribution still has the feel of a zero-sum game. Five days after Israel received 700,000 doses of the Pfizer-BioNtech vaccine, Pfizer told other non-U.S. customers that it would cut supplies while it briefly closed a facility in Belgium.

The disparity in vaccine allocation is the product of a company struggling to apportion doses while demand far exceeds supply. Stephanie Baker and Cynthia Koons reported for Bloomberg Businessweek that the company has determined how many doses a country gets through an opaque process that appears to involve a mix of order size, position in the queue, production forecasts, calls from world leaders, and of course the desire to make a profit.

See omnystudio.com/listener for privacy information.

In recent months, GOP lawmakers have heaped criticism on Democratic governors for how they handled outbreaks at nursing homes early in the pandemic. Michigan Republicans, who have been hostile to Governor Gretchen Whitmer throughout the crisis, are now asking the state’s attorney general to investigate how she coped with that challenge.

Republicans say that people died unnecessarily thanks to Whitmer’s order that nursing homes readmit residents with Covid-19 if they had capacity and quarantine capabilities. David Welch reports that Michigan’s fatality rate was lower than the national average, and many of those on the pandemic’s front line dispute the assertions.

See omnystudio.com/listener for privacy information.

Now that Johnson & Johnson’s Covid-19 vaccine has been cleared by regulators, the company needs to ramp up doses fast. J and J is looking for manufacturing partnerships to increase supply. Riley Griffin spoke to the company’s chief executive officer, Alex Gorsky about his plan to immunize 20 million Americans by the end of the month, and 100 million by the end of June.

See omnystudio.com/listener for privacy information.

New York City’s museums, sports arenas and entertainment venues are slowly coming back to life. But the sector has contracted dramatically under the pressure of the global pandemic. Jobs in arts, entertainment and recreation fell the most of all the city’s economic sectors, erasing a decade of gains in what was one of New York’s most vibrant industries. Spencer Norris explains what that means for cultural institutions, and the city that was one of the sector’s biggest boosters.

See omnystudio.com/listener for privacy information.

Almost a month after U.S. vaccination campaigns ramped up to give Covid-19 shots to more than a million people a day, their second doses are coming due. That’s putting a strain on state rollouts, and leaving some people without complete immunizations. John Tozzi reports that as President Joe Biden accelerates purchases and distribution, critical weaknesses in the system are starting to show.

See omnystudio.com/listener for privacy information.

Nine vaccines have proved effective at protecting people from developing symptoms of Covid-19. But we don’t know yet how good they are at preventing asymptomatic infections, and keeping vaccinated people from passing the virus on to others. The good news is that preliminary signs suggest they do at least some of both. Jason Gale discusses what we’re learning about how the shots work, as vaccination campaigns continue around the world.

See omnystudio.com/listener for privacy information.